Investors Urged to Join PepGen Inc. Lawsuit
The Schall Law Firm, a notable national shareholder rights litigation firm, has issued a reminder to investors regarding a class action lawsuit against PepGen Inc. ("PepGen" or "the Company") PEPG. The firm indicates violations of the Securities Exchange Act of 1934 and related regulatory rules have occurred.
Class Action Details and Eligibility
Shareholders who purchased PepGen securities between March 7, 2024, and March 3, 2025, are invited to reach out to the Schall Law Firm to discuss their eligibility for the class action lawsuit. This is an important opportunity for those who may have experienced losses as a result.
How to Participate
Participating in the lawsuit involves contacting the firm before the upcoming deadline on August 8, 2025. It's highly encouraged for those affected to take action and ensure they are represented within the potential class.
Understanding the Claims Against PepGen
The lawsuit claims that PepGen made false and misleading statements regarding its drug candidate PGN-EDO51. It alleges that the product was not as safe or effective as the Company had suggested. Moreover, the CONNECT2 study, crucial for potential FDA approval, was purportedly flawed and posed risks to trial participants.
Fact Insights
According to the complaint, these misstatements led to significant investor losses when the reality of the situation was revealed. The damage incurred by investors underscores the critical nature of transparency in corporate statements.
Contacting the Schall Law Firm for More Information
For any shareholders who believe they qualify, they should consider reaching out to Brian Schall at the Schall Law Firm. The firm is located at 2049 Century Park East, Suite 2460, with contact availability at 310-301-3335. Furthermore, inquiries can be directed through the firm's website.
The Importance of Representation in Securities Actions
It should be noted that the class defined by this action has not yet been certified. Until that certification happens, potential class members are not officially represented. Those who choose inaction may remain absent members of the class.
Conclusion: Safeguarding Investor Rights
The Schall Law Firm has a strong emphasis on protecting shareholder rights and represents investors globally. Their expertise in securities class action lawsuits is vital for those affected by misleading corporate communications.
Next Steps for Affected Investors
Investors are advised to act swiftly by reaching out to the Schall Law Firm, thus ensuring their participation in the ongoing legal actions against PepGen Inc.
Frequently Asked Questions
What should I do if I purchased PepGen stock during the class period?
If you bought PepGen stock between March 7, 2024, and March 3, 2025, it’s advisable to contact the Schall Law Firm to discuss potential participation in the class action lawsuit.
How can I contact the Schall Law Firm?
You can reach the firm by calling 310-301-3335 or visiting their website at www.schallfirm.com.
What are the risks involved in this lawsuit?
Like any legal action, participating in a lawsuit involves risks such as the outcome not being favorable. However, it provides a chance for potential recovery of losses.
Is there a deadline to join the class action?
Yes, the deadline to join the class action lawsuit is August 8, 2025. It is critical to act before this date.
What will happen if the class loses?
If the class action does not succeed, participants may not recover any losses. However, the potential for recovery often makes pursuing legal action worthwhile.
